New diabetes clinical trial: Precision T1D Platform

Published on: 2026-05-18T04:00:00Z
Conditions: Type 1 Diabetes; T1D Diabetic Chronic Kidney Disease; T1D Heart Failure; Cardio-renal Vascular Function and Failure
Interventions: Drug: Finerenone; Drug: Sotagliflozin
Sponsors: Oregon Health and Science University; University of Michigan; Breakthrough T1D
Not yet recruiting
https://ift.tt/VylCTaw